the loss of 15-30% of its body weight, the bear does not eat, drink, urinate, or defecate until its emergence from hibernation in April. Oxygen consumption decreases ϳ50%, but a heavily insulated pelt, a relatively low body surface area-to-body mass ratio, and a reduction in peripheral blood flow limit the decline in body temperature from 37-39°C in summer to 31-35°C (23, 26, 30) . The respiratory quotient decreases to values approaching 0.6, indicating not only that lipid oxidation has become the principal source of energy but also that metabolic CO 2 is utilized in synthetic processes, as, for example, in the replenishment of Krebs cycle intermediates via the pyruvate carboxylase reaction. Lean body mass, calculated using measurements of total body water based on the dilution of deuterated water, is preserved in part because the ammonia nitrogen liberated by protein catabolism or by the breakdown of urea is reincorporated into new protein. Thus, in denning bears, 14 C label from injected [U- 14 C]glycerol was found in alanine, serine, and plasma proteins, and nitrogen from administered doubly labeled 15 N urea appeared in the amino acids ornithine, arginine, glycine, tyrosine, phenylalanine, and threonine (1, 24, 25) . Since urea is a major determinant of urinary volume and since there is no net synthesis of urea, urine is not excreted. Nonurinary water losses, as in expired air, are replaced by metabolic water arising from fatty acid oxidation. Blood chemistries, including glucose, amino acids, plasma proteins, electrolytes, and urea nitrogen, remain relatively stable (26, 34) .
Previous studies have shown that growth hormone (GH) has important effects on fat and protein metabolism (22) , yet its role in the preparation for and adaptation to winter denning has not previously been explored. In states of caloric restriction, increased GH secretion promotes lipolysis in adipose tissue and fatty acid metabolism in animal models and human studies (22, 42) . Nørrelund et al. (28) have reported that this effect of GH on fatty acid metabolism is important for protein-sparing effects. Thus, during periods of nutritional restriction, increased GH secretion might promote increased fatty acid metabolism and thereby help to protect protein stores. In contrast, obesity is associated with a diminution in both basal and stimulated GH secretion, which may facilitate fat deposition (22) , whereas little change in levels of IGF-I is noted. Multiple factors, including increased insulin levels and bioavailability of IGFs, may contribute to the suppression of GH secretion in obesity (10, 15) .
In addition to effects on fat metabolism, GH stimulates the production of insulin-like growth factor-I (IGF-I), which mediates major effects of GH on body growth and anabolism and provides a useful serum marker that reflects integrated levels of GH secretion (31) . Adequate nutrition also plays a critical role in regulating IGF-I, and protein nutrition is particularly important in maintaining the ability of GH to regulate IGF-I levels (37) . Since the denning bear is remarkably efficient in maintaining lean body mass (19, 20) and derives the bulk of its energy from fatty acid oxidation, we asked whether changes in the GH-IGF axis might contribute to seasonal regulation of metabolism and the adaptation of Ursus americanus to winter denning.
MATERIALS AND METHODS

Materials.
Recombinant human IGF-I was purchased from Bachem (Torrance, CA). Recombinant human growth hormone was generously provided by Genentech (South San Francisco, CA). C-2 silica cartridges were obtained from Varian (Harbor City, CA). Endoglycosidase F and staphylococcal protein A (Pansorbin) were purchased from Calbiochem. Reagents for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were purchased from Bio-Rad (Richmond, CA), and prestained molecular weight standards were obtained from Amersham (Arlington Heights, IL). Polyclonal rabbit antiserum against human IGF-I was provided by the National Hormone and Pituitary Program (Baltimore, MD), and polyclonal antiserum, which recognizes human IGF-binding protein (IGFBP)-2, was kindly provided by Dr. Ron Rosenfeld.
Animals and blood collection. Studies were limited to adult male bears to avoid confounding effects of age-related changes in blood levels of IGF-I and effects of pregnancy on circulating levels of IGFBPs and/or IGFs. Studies on wild black bears were approved by the Minnesota Department of Natural Resources, and studies on captive bears were approved by the Carle Foundation and the University of Illinois at Chicago Institutional Animal Care and Use Committees.
Wild radio-collared bears in north-central Minnesota were studied between December 1988 and February 1992. Animals were captured temporarily in barrel traps during the summer months and handled in dens during winter. These bears were immobilized by intramuscular injection with ketamine-xylazine (4.4/1.8 mg/kg) in the summer and ketamine-promazine (12.0/0.6 mg/kg) in the winter. Blood was drawn from the femoral vein per vacutainer in glass tubes and then placed on ice in the field until centrifugation of blood specimens was carried out within 6 h after collection. Serum was stored in aliquots at Ϫ20°C.
Captive male black bears were housed outdoors and were provided with a cement culvert, where they den in winter months. Denning was initiated in mid-late November by withdrawal of food, and animals were allowed access to food again in mid-March. After emerging from the den, animals consumed Յ3.6 kg/day of dog chow ("Generic Chunk Style;" Wells Pet Food, Monmouth, IL) until midsummer, when food intake was increased, until they were consuming 5.5-6.4 kg/day before denning. Animals were allowed free access to water, although spontaneous water intake does not occur during denning. For blood drawing, captive animals were immobilized by administration of 2 mg/kg tiletamine with 2 mg/kg im zolazepam (Elkins-Sinn, Cherry Hill, NJ). Blood was drawn from the femoral vein by syringe and then transferred to plain or heparinized glass tubes and centrifuged at 4°C. Serum and plasma were stored in aliquots at Ϫ20°C. IGF-I levels were measured (below) in serum samples collected serially over the course of 3 yr from three captive adult male bears.
Human GH (hGH) was reconstituted in bacteriostatic water and stored at 22°C between use. Three animals, weighing between 154 and 182 kg at baseline, were injected with 18 mg im GH daily (0.1-0.12 mg·kg Ϫ1 ·day Ϫ1 ) for 6 days beginning 30 days after the initiation of denning. Blood samples were obtained for analysis of IGF-I and IGFBP levels immediately before the first injection of hGH, 24 h after the last dose, and 1 wk after withdrawal.
Serum extraction and IGF-I radioimmunoassay. Serum IGFBPs were removed by solid-phase extraction prior to radioimmunoassay, as reported previously (33) . Briefly, 100-l aliquots of serum were acidified overnight at 4°C with 1.6 ml of 1 M acetic acid, and then 1.5 ml was loaded onto 1-ml C-2 cartridges under vacuum. Cartridges were rinsed with acetic acid, and residual IGFBPs were eluted with 3 ml of 20% acetonitrile-1% trifluoroacetic acid (vol/vol). IGFs were eluted with 45% acetonitrile-1% trifluoroacetic acid and then dried under vacuum during centrifugation and stored at Ϫ20°C for assay within 1 wk. Previous studies have shown that this procedure results in the recovery of ϳ75% of recombinant human IGF-I and effectively removes IGFBPs found in human and both fetal and adult rat serum (33) .
Recombinant human IGF-I was iodinated by lactoperoxidase and then repurified by immunoaffinity chromatography and stored at Ϫ20°C for use within 5 wk, as reported previously (39) . Nonequilibrium double-antibody immunoassay was performed, using human IGF-I as a standard as before (33) .
Analysis of IGFBPs. IGF-binding activity was estimated by 1-h incubation of appropriate amounts of bear serum or C-2 serum extract with ϳ1 ϫ 10 4 counts/min 125 I-IGF-I in 250 l of binding buffer and precipitation of bound tracer with 200 l of human ␥-globulin (5 g/l) and 500 l of polyethylene glycol (250 g/l) at 22°C, as reported previously (41) . Nonspecific precipitation was estimated in the presence of 250 ng/ml unlabeled IGF-I and subtracted from all results.
For Western ligand blotting, 2 l of serum or corresponding amounts of C-2 extracts were heated for 10 min at 65°C in nonreducing sample buffer and then loaded for 13% acrylamide SDS-PAGE. Proteins were electrotransferred onto 0.45 M nitrocellulose, and membranes were sequentially blocked with 3% vol/vol Nonidet P-40, 10 g/l bovine serum albumin (BSA), and 0.1% Tween in 150 mM NaCl and 10 mM Tris, pH 7.4, and then probed overnight at 4°C with 125 I-IGF-I in 10 g/l BSA, 0.1% Tween, and Tris-saline, as reported previously (39). Membranes were rinsed and then dried and IGFBPs identified by autoradiography at Ϫ80°C with enhancing screens. Relative levels of IGFBPs were determined by densitometry, as described previously (40) .
For studies of IGFBP-2, immunoprecipitation and Western blotting studies were performed as reported previously (27) . In brief, staphylococcal protein A was washed in Tris-saline and then incubated with polyclonal antiserum against human IGFBP-2 to adsorb antibodies or with nonimmune rabbit serum as a control. For studies, 5 l of bear serum was preincubated with fresh protein A in Tris-saline to remove proteins that bind nonspecifically and then microfuged, and the supernatant then was incubated with antibody-coated protein A. Washed pellets were heated in nonreducing SDS-PAGE sample buffer and microfuged, and the supernatant was loaded for 13% nonreducing SDS-PAGE and Western ligand blotting (above).
To determine whether 40-to 48-kDa IGFBPs were N-glycosylated and represented IGFBP-3, 3 l of serum was incubated for 3 h at 37°C with 250 mU endoglycosidase F in 75 l of H 2O, adjusted to pH 4.8 with 5 l of 0.2 N HCl. Reactions were terminated by addition of 80 l of 2ϫ SDS-PAGE sample buffer and heated for 10 min at 65°C in preparation for 13% nonreducing SDS-PAGE and Western ligand blotting, as described above.
Statistical analysis. Differences in serum IGF-I levels at different times of the year in wild and captive bears and effects of GH in captive bears were tested for significance using repeated-measures analysis of variance (SAS Proc Mixed), with Tukey's test to calculate P values for pairwise comparisons. Statistical significance was assigned for P values Ͻ0.05.
viously (33) . We confirmed that bear IGFBPs were removed based on measurement of IGF-binding activity (Fig. 1A) and Western ligand blotting (Fig. 1B ). Next, we tested bear serum extracts for the presence of immunoreactive IGF-I. As shown in Fig. 1C , bear serum extracts compete in parallel with recombinant human IGF-I for binding by antiserum against human IGF-I. Recombinant human IGF-II is not detected in this assay (Fig. 1C) , indicating that this assay is specific for IGF-I. Serum collected from a bear in December during early winter denning (Fig. 1C, छ) was less potent than a sample collected from the same bear in October (Fig. 1C, □) before denning, suggesting that levels of IGF-I might be lower during denning.
IGF-I levels in wild bears. We next examined IGF-I levels in serum samples collected during different times of the year from radio-collared bears living in the wild. As shown in Fig. 2A , IGF-I levels in individual bears were higher during the active season (May-August) than during early (December and January) or later denning (February and March). When levels for all bears were combined for each season (Fig. 2B) , levels of IGF-I were significantly higher in bears during the active season compared with levels during early denning. Interestingly, levels of IGF-I tended to rise in bears in later compared with early denning despite continued starvation, suggesting that IGF-I levels may not be regulated primarily by nutrition in late denning.
IGF-I levels in captive bears. To better define seasonal changes in circulating levels of IGF-I in black bears, we next examined IGF-I levels in captive bears, where more frequent measurements were possible. Figure 3A shows IGF-I levels in serum samples collected from three adult male black bears over the course of 3 yr. Figure 3B shows the results for all three bears combined according to the month of the year. Figure 3C compares IGF-I levels measured in spring (post-denning; April and May), summer (June-August), autumn (September-November), early denning (December and January), and later denning (February and March). As shown in Fig. 3A , serum levels of IGF-I followed a similar pattern of regulation in each of the three bears over the course of several years. IGF-I levels were high in bears in the spring and summer and then decreased in the autumn, when bears increase food intake in preparation for denning. IGF-I levels tended to fall further in early denning but increased later during denning, exceeding predenning levels despite prolonged starvation. Taken together, these results indicate that circulating levels of IGF-I decline in autumn, when bears are in preparation for denning, before their food intake is reduced, and increase during late denning despite prolonged starvation.
Circulating IGFBPs. We also examined levels of IGFBPs in serum collected from captive bears (Fig. 4) . Western ligand blotting demonstrates that bear serum contains IGFBPs with molecular weights of 40 -48, 36, 30, and 24 kDa (Fig. 4A,  lane 1) . As shown in Fig. 4A, lane 2 
. IGF-I levels in wild bears.
A: levels in individual bears. Serum samples were collected from radio-collared bears living in the wild, and IGF-I levels were measured by immunoassay after acidification and C-2 solid-phase extraction to remove IGFBPs as in Fig. 1 . Levels for individual bears are connected by solid lines. B: IGF-I levels during active living and early and late denning. Results were combined for all samples collected from bears during spring and summer (April-August), when bears were active; early winter (December and January), when bears were denning; and later winter (February and March), before bears emerged from their dens. Means Ϯ SE are shown. Statistical significance of differences between groups was determined by repeated-measures ANOVA and Tukey's post hoc test, as described in MATE-RIALS AND METHODS, and lowercase letters are shown to identify groups that are statistically the same (i.e., not different from each other). and increase during late denning (March) and remain high in animals living during the active season, paralleling changes seen in serum levels of IGF-I (Fig. 3) . In contrast, levels of IGFBP-2 are highest during early denning, decline during later denning, and remain low during active living. As shown in Fig.  4D , more prolonged autoradiography (48 h) of the sample Western blot revealed that 24-and 30-kDa IGFBP levels also increase during early denning and decrease during later denning and throughout the active season.
Effects of GH treatment on IGF-I and IGFBP levels in denning bears. Changes in circulating levels of IGF-I and
IGFBPs may reflect differences in GH secretion and/or action. We were not able to measure circulating levels of GH in bears using immunoassays for human or bovine GH. To determine whether bears remain responsive to GH during early denning, when IGF-I levels are lowest, we treated three adult male bears living in captivity with recombinant hGH for 6 days beginning 30 days after the onset of denning and studied effects on IGF-I and IGFBP level at baseline, 24 h after the last GH injection, and 7 days later.
As shown in Fig. 5A , left, serum levels of IGF-I increased approximately fourfold with GH treatment and declined after GH was discontinued in all three bears, demonstrating that bears remain responsive to GH during early denning. We also examined effects of GH treatment on IGFBPs by Western ligand blotting. As shown in Fig. 5, A and B , levels of IGFBP-3 increased with GH treatment and declined after GH treatment in all three bears, whereas levels of IGFBP-2 declined with GH treatment and increased after GH was discontinued. Levels of 30-kDa IGFBPs also increased with GH treatment and declined after GH was discontinued.
Effects of GH on body weight and metabolism. We also examined metabolic effects of GH treatment in denning bears. As shown in Fig. 6 , GH treatment decreased serum levels of urea nitrogen in all three bears, and this effect was reversed after GH was discontinued. In contrast, GH treatment had no effect on serum creatinine levels, indicating that GH lowered blood urea nitrogen (BUN) levels due to an effect on protein metabolism and/or ureagenesis and not kidney function.
We also considered the effects of GH on body weight and metabolism in denning bears. As shown in Fig. 7A , denning bears lose 1-1.5 kg/day, and this increased to ϳ2 kg/day during GH treatment. This accelerated weight loss was accompanied by a marked increase in circulating levels of free fatty acids (Fig. 7B ) and ␤-hydroxybuyrate (Fig. 7C) . Serum levels of bicarbonate were reduced (Fig. 7D) , whereas the anion gap (the difference between measured cations and measured anions, usually reflecting the increased accumulation of lactic or keto acids) was increased (Fig. 7E) . As shown in Fig. 7F , GH treatment did not result in a significant change in lactate levels, indicating that the decline in bicarbonate level and increase in anion gap reflected the accumulation of excessive keto acids. Effects on weight loss and levels of free fatty acids, ␤-hydroxybutyrate, bicarbonate, and unmeasured anions were all reversed after GH was discontinued.
As shown in Fig. 7G , effects on glucose levels were more variable and were not statistically significant. In contrast, insulin levels increased markedly in all three bears during GH treatment, whereas levels of glucagon were not significantly affected by GH. Together, these results indicate that GH treatment of denning bears results in accelerated weight loss and the accumulation of significant amounts of keto acids, reflecting accelerated lipolysis and ketogenesis, despite accompanying hyperinsulinemia.
DISCUSSION
In this study, we examined seasonal changes in the GH-IGF-I system in black bears living in the wild and in captivity. Donahue et al. (7) reported that circulating IGF-I levels are decreased in denning bears compared with pre-and postdenning levels, but they did not examine changes during the course of denning. Our initial studies in wild bears indicated that serum levels of IGF-I are high in the spring and summer and lower in early denning (December and January) and may rise during later denning (February and March). More detailed studies in captive bears revealed that serum levels of IGF-I decline in autumn, when bears are hyperphagic and gaining weight in preparation for winter, reach a nadir in early denning, and increase later in the den, exceeding predenning levels despite continued starvation. This pattern was highly reproducible in three individual bears studied over the course of 3 yr. Previous studies in humans and other species show that circulating IGF-I levels are strongly regulated by nutrition and are suppressed by fasting and malnutrition (22, 36) . However, our results indicate that factors other than nutrition also play a major role in determining levels of IGF-I in the bear during the course of the year, since IGF-I levels decline in autumn despite adequate nutrition, and IGF-I levels increase later in the den despite prolonged fasting.
Serum levels of IGF-I are strongly regulated by GH, and seasonal changes in IGF-I levels in black bears may reflect alterations in GH secretion and/or action. Although we were not able to measure bear GH directly, several observations suggest that the decline in IGF-I levels in autumn and early denning and the subsequent increase during later denning are likely to be due, at least in part, to seasonal changes in GH secretion. Treatment of bears with exogenous GH during early denning, when IGF-I levels are at their nadir, resulted in a marked increase in serum IGF-I levels, and this was reversed after GH was withdrawn, indicating that black bears remain responsive to GH during early denning. One limitation of this study is that the small number of captive bears available for study (n ϭ 3) precluded the possibility of having a separate control group, so each bear served as its control. Although it is possible that the changes we observed could be due to other factors, the marked effects of GH treatment and withdrawal on serum levels of IGF-I are consistent with well-known effects of GH on IGF-I levels in other species (16) , supporting the concept that they reflect effects of GH treatment in denning bears.
GH treatment also reversed effects of early denning on serum levels of IGFBP-2 and -3, suggesting that reduced GH effects also contribute to changes in levels of these IGFBPs during early denning. However, changes in IGFBP proteases (4, 5) may also contribute to seasonal differences in circulating levels of IGFBPs but were not studied.
We also observed other effects of GH treatment in denning bears, including effects on protein and lipid metabolism. GH treatment reduced levels of BUN but not creatinine, indicating that this change in BUN reflects an effect on nitrogen metabolism and not renal function. GH treatment may reduce levels of BUN by several mechanisms by both suppressing mobilization of protein stores (13) and reducing amino acid catabolism and urea production at the level of the liver (12) . Based on levels of IGF-I, the effects of endogenous GH appear to be at their nadir during early denning, indicating that GH probably does not play a major role in maintaining nitrogen balance during this phase of winter denning. On the other hand, since protein nutrition plays an important role in maintaining GH responsiveness (36) , the ability of the bear to maintain nitrogen balance may be important in maintaining tissue sensitivity to GH during winter denning.
Exogenous GH also exerted important effects on fat metabolism in denning in bears. Treatment with GH during early denning resulted in accelerated weight loss and a marked increase in circulating levels of free fatty acids and ␤-hydroxybutyrate that was reversed after GH was discontinued, demonstrating that GH can strongly stimulate fatty acid mobilization and metabolism in bears. In contrast, GH had variable effects on glucose levels. The effect of GH on fat metabolism was not due to either insulin deficiency or glucagon excess, since insulin levels were high and glucagon levels were not altered during GH treatment. Together, these findings indicate that GH exerts important effects on fat metabolism in bears, consistent with the ability of GH to stimulate lipolysis in isolated adipocytes (6) and promote fat metabolism in vivo (3, 18, 22) .
The effect of exogenous GH on fat metabolism in denning bears was profound enough to promote the development of a ketaocidosis demonstrated by a reduction in serum levels of bicarbonate and an increase in the "anion gap," reflecting an increase in levels of unmeasured anions, including ␤-hydroxybutyrate. These effects were all reversed after withdrawal of GH treatment. GH has occasionally been associated with ketoacidosis in clinical settings, including acromegaly (17, 44) , and in obese subjects provided high-dose GH treatment during an extended fast (8) . Although GH is thought to play an important role in the adaptation to fasting, where increased lipolysis and fatty acid metabolism may be important for protecting protein stores (21, 28) , this study highlights the potential risk of GH treatment during catabolic states, including nutritional deprivation or severe illness (35) .
The mechanisms responsible for seasonal changes in the activity of the GH-IGF-I axis in the bear remain to be determined. Previous studies indicate that hypothalamic-pituitary control of thyroid and gonadal function is altered during winter denning in bears. Serum levels of testosterone decrease in male bears in autumn, remain low in early denning, and increase later before bears emerge from the den (11, 29) , similar to the pattern we observed for changes in IGF-I levels. Subsequent studies showed that levels of gonadotropins are decreased, and the ability of gonadotropin-releasing hormone to stimulate gonadotropin secretion is impaired in fall and early denning and then recovers (14) , indicating that seasonal changes in testosterone levels reflect changes in hypothalamic-pituitary function. Similarly, thyroid hormone levels also are decreased during denning, and testing with thyrotropin-releasing hormone indicates that this reflects changes in hypothalamic function (2). Webster et al. (43) have reported that photoperiod contributes to seasonal regulation of GH secretion and IGF-I levels in reindeer. It is interesting to speculate that seasonal changes in day length may also contribute to alterations in GH secretion in black bears in autumn and early denning, when IGF-I levels decline, and in later denning, when IGF-I levels increase.
Reactivation of pituitary function, including the GH-IGF-I axis, during late denning may help to prepare the bear for emergence from the den in multiple ways. Donahue et al. (7) have suggested that increased GH-IGF-I activity may promote bone remodeling and formation in bears at the end of denning. Interestingly, the rise in IGF-I levels we observed closely parallels the increase in metabolic rate and body temperature in late denning reported by Toien et al. (38) . Recent findings in laboratory animals (32) suggest the interesting possibility that alterations in the GH-IGF-I axis may contribute to seasonal changes in metabolism and thermoregulation in the bear.
In summary, we found that activity of the GH-IGF-I axis is seasonally regulated (decreased in autumn and early denning and restored in later denning) in the black bear living in the wild or in captivity. Seasonal changes in IGF-I levels do not reflect changes in food intake but may be regulated by other factors, including day length. Physiologically, we speculate that decreased GH activity during autumn, when bears are hyperphagic, may help bears store large amounts of body fat required to survive prolonged starvation during denning. Reduced GH activity during early denning may help to conserve fat stores, the only source of energy and water available during prolonged denning. Later, increased GH activity may help to mobilize remaining fat stores, which may be important for proteinsparing effects of GH, and help prepare the bear for active living outside the den. Together, the results of these studies provide new insight into the regulation of the GH-IGF-I axis in the black bear and suggest how modulation of the GH-IGF axis may contribute to the integrated regulation of metabolism in the American black bear, a "metabolic marvel."
